Norges Bank Repligen Corp Transaction History
Norges Bank
- $736 Billion
- Q4 2024
A detailed history of Norges Bank transactions in Repligen Corp stock. As of the latest transaction made, Norges Bank holds 166,975 shares of RGEN stock, worth $24.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
166,975Holding current value
$24.3 Million% of portfolio
0.0%Shares
50 transactions
Others Institutions Holding RGEN
# of Institutions
476Shares Held
55.6MCall Options Held
311KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.1 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$931 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$743 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$237 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$207 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.09B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....